See for Pasireotide B2305 Study Group.
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
Version of Record online: 27 MAR 2014
© 2014 John Wiley & Sons Ltd
Volume 81, Issue 3, pages 408–417, September 2014
How to Cite
Pivonello, R., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Trovato, A., Hughes, G., Salgado, L. R., Lacroix, A., Schopohl, J., Biller, B. M.K. and Pasireotide B2305 Study Group (2014), Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clinical Endocrinology, 81: 408–417. doi: 10.1111/cen.12431
- Issue online: 25 JUL 2014
- Version of Record online: 27 MAR 2014
- Accepted manuscript online: 17 FEB 2014 08:55AM EST
- Manuscript Accepted: 11 FEB 2014
- Manuscript Revised: 10 FEB 2014
- Manuscript Revised: 28 JAN 2014
- Manuscript Received: 27 SEP 2013
- Novartis Pharma AG
- Novartis Pharmaceuticals Corporation
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.